Détails du rapport Vaer
Âge: 48 ans
Région : Outside US
- Patient décédé?
- Renseignements sur les vaccins
Nom: COVID19 (COVID19 (PFIZER-BIONTECH))
Type : Coronavirus 2019 vaccine
- Date de réception du rapport
- Date à laquelle le formulaire est complèté
- Date de vaccination
- Date d’apparition
- Nombre de jours (date d’apparition – date de vaccination)
- Description de l’événement indésirable
hypotension; paroxysmal cough; possible allergy; intense weakness; myalgia; this is a spontaneous report received from a contactable reporter(s) (physician) from the regulatory authority-web. regulatory number: gr-greof-20217674 (ra). a 48 year-old female patient received bnt162b2 (comirnaty), administration date 02sep2021 (batch/lot number: unknown) at the age of 48 years as dose 1, single for covid-19 immunization. relevant medical history included: "pollen allergy" (unspecified if ongoing), notes: pollen allergy (paroxysmal intense cough); "hypothyroidism" (unspecified if ongoing). concomitant medication(s) included: t4 taken for hypothyroidism, start date: 01sep2008. the following information was reported: hypotension (hospitalization) with onset 02sep2021, outcome "recovering", described as "hypotension"; cough (hospitalization) with onset 02sep2021, outcome "recovering", described as "paroxysmal cough"; hypersensitivity (hospitalization) with onset 02sep2021, outcome "recovering", described as "possible allergy"; asthenia (hospitalization) with onset 02sep2021, outcome "recovering", described as "intense weakness"; myalgia (hospitalization) with onset 02sep2021, outcome "recovering", described as "myalgia". the events "hypotension", "paroxysmal cough", "possible allergy", "intense weakness" and "myalgia" were evaluated at the emergency room visit. the patient underwent the following laboratory tests and procedures: cardiac function test: without abnormal findings; pulmonary function test: without abnormal findings. therapeutic measures were taken as a result of hypotension, cough, hypersensitivity, asthenia, myalgia. it was reported that, the patient was admitted to the er. she was administered normal solution, feistily, solu cortef 250 mg iv. adrenaline was not administered. pulmonary and cardiological examination without abnormal findings. during her hospitalization she was hemodynamically stable with paroxysmal cough (under treatment with antihistamines per os), in remission within 48 hours and intense weakness and myalgia. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected
- Données de laboratoire
test name: cardiological examination; result unstructured data: test result:without abnormal findings; test name: pulmonary examination; result unstructured data: test result:without abnormal findings
- Liste des symptômes
asthenia cough hypersensitivity myalgia hypotension pulmonary function test cardiac function test
- Patient décédé?
- Date de décès
- Anomalie congénitale
- Vaccin administré par :
- Vaccin acheté par :
- Visite d’un patient à l’urgence?
- Patient hospitalisé?
- Séjour à l’hôpital
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Maladie actuelle